Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2011
07/12/2011US7977380 Inhibitors of plasma kallikrein
07/12/2011US7977379 Method for angiogenesis inhibition or immunostimulation
07/12/2011US7977378 Compositions and methods for enhancing weight-loss by cyclical administration of compounds
07/12/2011US7977377 Treatment of depressive disorders
07/12/2011US7977376 For therapy of allergic or inflammatory disorders of the eye and nose
07/12/2011US7977375 Antibiotic and method of production thereof
07/12/2011US7977374 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors
07/12/2011US7977373 Prodrugs of ion channel modulating compounds and uses thereof
07/12/2011US7977371 Pyrrole derivative having ureido group and aminocarbonyl group as substituents
07/12/2011US7977369 Via 3-hydroxymethyl-5-aziridinyl-1-1-methyl-2-(1H-indole-4,7-dione )propenol
07/12/2011US7977368 Pyrazolopyrrolidines as inhibitors of gamma secretase
07/12/2011US7977367 Substituted imidazole propanamide glucokinase activators
07/12/2011US7977366 Treating an inflammatory disorder or inhibiting respiratory burst in adherent neutrophils with chemical inhibitors of neutrophil activation
07/12/2011US7977365 Antiviral drugs for treatment of arenavirus infection
07/12/2011US7977364 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents
07/12/2011US7977363 Fungicides/bactericides for plant protection; exhibit a strong fortifying effect in plants; for controlling cereal diseases against Puccinia species, and diseases in viticulture and fruit and vegetable production against Botrytis, Venturia or Alternaria species; low toxicity; tolrerance
07/12/2011US7977362 Alpha-(N-benzenesulfonamido)cycloalkyl derivatives
07/12/2011US7977361 Nitro-imidazole hypoxia imaging agent
07/12/2011US7977360 Benzo[d]isoxazol-3-yl-amine compounds and their use as vanilloid receptor ligands
07/12/2011US7977359 5-lipdxygenase-activating protein (FLAP) inhibitors
07/12/2011US7977358 Pyrazol derivatives
07/12/2011US7977357 Polymorphic forms of 3-(4-amino-1-oxo-1, 3 dihydro-isoindo1-2-yl)-piperidine-2,6-dione
07/12/2011US7977356 Optical isomers of an Iloperidone metabolite
07/12/2011US7977355 N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl
07/12/2011US7977354 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
07/12/2011US7977353 Heterocyclic aromatic compounds useful as growth hormone secretagogues
07/12/2011US7977352 Triazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases
07/12/2011US7977351 Heteroaryl dihydroindolones as kinase inhibitors
07/12/2011US7977350 CCR1 antagonists and methods of use therefor
07/12/2011US7977349 Substituted quinolones III
07/12/2011US7977348 Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α
07/12/2011US7977347 inhibitors of epidermal growth factor receptor tyrosine kinase; anticancer; 6-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)hexanoic acid
07/12/2011US7977346 Spiro compounds and methods of use
07/12/2011US7977345 c-MET modulators and method of use
07/12/2011US7977344 Compounds
07/12/2011US7977343 Adenine derivatives
07/12/2011US7977342 HCV inhibiting bi-cyclic pyrimidines
07/12/2011US7977340 Antibacterial compositions
07/12/2011US7977339 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
07/12/2011US7977338 Phenylacetamides being FLT3 inhibitors
07/12/2011US7977337 Quinoline derivatives and their use as 5-HT6 ligands
07/12/2011US7977336 Aminopyrimidine derivatives as PLK1 inhibitors
07/12/2011US7977335 Methods of preventing and reducing the severity of stress-associated conditions
07/12/2011US7977334 N-(3-{2-[3-(6-amino-benzimidazol-1-yl)-1,1-dimethyl-propylamino]-1-hydroxy-ethyl}-phenyl)-benzenesulphonamide; beta(3)-Adrenoceptor agonists; antidiabetic, obesity modulator, insulin resistance
07/12/2011US7977333 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
07/12/2011US7977331 Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
07/12/2011US7977330 Salts and crystal modifications thereof
07/12/2011US7977329 Obesity therapy; using 3-benzoazepine compound
07/12/2011US7977328 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
07/12/2011US7977327 Substituted pyrrolidine derivative
07/12/2011US7977326 Supportive treatment of liver disease
07/12/2011US7977325 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents
07/12/2011US7977324 Process for preparing malathion for pharmaceutical use
07/12/2011US7977323 C2-C5-alkyl-imidazole-bisphosphonates
07/12/2011US7977321 Small interfering RNAs targeting feline herpes virus
07/12/2011US7977320 Method of increasing efficacy of tumor cell killing using combinations of anti-neoplastic agents
07/12/2011US7977319 Ultra-high fiber supplement and method of reducing weight, cardiovascular risks and ingested toxins
07/12/2011US7977318 Derivative of glucose and of vitamin F, compositions comprising it, uses and preparation process
07/12/2011US7977312 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures
07/12/2011US7977307 Method for reducing pain with ziconotide and morphine
07/12/2011US7977304 FK 228 derivates as HDAC inhibitors
07/12/2011US7977068 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
07/12/2011US7977049 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
07/12/2011US7977045 Aqueous-based pharmaceutical composition
07/12/2011US7976881 Combinations of vasoactive agents, their use in the pharmaceutical and cosmetic field, and formulations containing them
07/12/2011US7976880 Pregnane glycoside compositions and Caralluma extract products and uses thereof
07/12/2011US7976879 Nutritional supplement product to suppress age-related decline in cognitive capacity and other aging functions
07/12/2011US7976876 Anti-bacterial, anti-virus, and anti-fungus composition, its preparation and use
07/12/2011US7976875 Biofilm extracellular polysaccharide solvating system
07/12/2011US7976871 Modified release composition of highly soluble drugs
07/12/2011US7976870 using a sustained release oral dosage form of a therapeutically effective amount of the drug such as minocycline hydrochloride incorporated in a matrix of biocompatible, hydrophilic polymer of specified swelling properties and erosion rate
07/12/2011US7976869 Fenofibrate tablets
07/12/2011US7976867 Multilayer; backing layer containing reservoir, covering with aperture , adhesive and lining
07/12/2011US7976862 Longitudinal body; polymeric coating of polyalkyl(meth)acrylate and/or aromatic poly(meth)acrylate; and poly(ethylene-co-vinyl acetate); triamcinolone acetonide; drug delivery to eye
07/12/2011US7976860 A porous protein matrix with a structural component partly or fully anchored in the matrix; at least one surface has a protein membrane crosslinked with the matrix; sufficient stability with improved flexibility, biocompatibility and absorption; vascular prosthetics
07/12/2011US7976853 Process for producing coated preparation
07/12/2011US7976852 Compositions and methods for cancer immunotherapy
07/12/2011US7976835 Methods and compositions for preventing and treating solid tumors
07/12/2011US7976834 For example, glycerol initiated multiarm polyethylene glycol modified with a polypeptide and then conjugated to a drug such as 5-fluorouracil; high drug-carrying capability; useful for hydrophilic and charge-bearing drugs as well
07/12/2011US7976833 Ophthalmic surgical irrigating solutions containing hyaluronidase and method for preventing post-operative intraocular pressure increases
07/12/2011US7976832 Neutralizing chemical warfare agents into less toxic products; barrier base cream of polytetrafluoethylene resins dispersed in perfluorinated polyether oils and an active amine or a polyalkenimine
07/12/2011US7976826 Compositions and methods relating to prevention of chemotherapy-induced alopecia
07/12/2011CA2669128C Treatment for multiple myeloma
07/12/2011CA2663401C Pyrido (2, 3-d) pyrimidinone compounds and their use as pi3 inhibitors
07/12/2011CA2651363C Triazolopyrazine derivatives useful as anti-cancer agents
07/12/2011CA2590159C Regimens for intra-articular viscosupplementation
07/12/2011CA2588398C Potassium salt of an hiv integrase inhibitor
07/12/2011CA2585053C Substituted n-acyl (hetero)aryl compounds as c-fms kinase inhibitors
07/12/2011CA2582479C Benzoimidazole derivatives useful as antiproliferative agents
07/12/2011CA2581156C Stabilized leukotriene b4 (ltb4) agent pharmaceutical formulation
07/12/2011CA2577879C Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i.epsilon.
07/12/2011CA2549498C A soft capsule of butylphthalide and a process for preparing the same
07/12/2011CA2526534C Compounds and methods for delivery of prostacyclin analogs
07/12/2011CA2524394C Novel benzodiazepine compounds, compositions and uses thereof
07/12/2011CA2517629C Phthalazinone derivatives
07/12/2011CA2516699C Hiv replication inhibiting pyrimidines and triazines
07/12/2011CA2511619C Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
07/12/2011CA2507656C Tiotropium-containing medicament combinations used for inhaling
07/12/2011CA2503451C Heterocyclic compounds and antitumor agent comprising the same as effective component
07/12/2011CA2501245C Method for producing solid galenic formulations using a crosslinked non-thermoplastic carrier